Stuart Wright M.sc.

Biography

Mr. Stuart Wright, M.Sc. serves as an Executive Director of CMC & Quality at i3 CanReg Inc. Mr. Wright has over twenty years experience in pharmaceutical manufacturing, materials management and quality assurance. His career includes senior manufacturing and operations positions with GlaxoSmithKline, Novartis, Torpharm and Delex Therapeutics. Mr. Wright served as a Director, Operations, Quality Assurance and Formulation Development for DELEX Therapeutics. He served as Senior Production Manager for TORPHARM Inc., where he successfully launched eight new products in the U.S., increased production efficiency and led a multi-million dollar facility expansion. Mr. Wright also spent several years in R&D with ICI in the United Kingdom and GlaxoSmithKline in Canada. At GlaxoSmithKline his responsibilities included Business Unit Manager, where under his direction he led the transition of multiple pharmaceutical products to a new production facility. oversees a large team of CMC and quality professionals that support each of canreg's clinical teams for all global markets. Mr. Wright serves as Director of Manufacturing Operations at Tribute Pharmaceuticals, Inc. He has more than twenty years of pharmaceutical industry experience in Canada and Scotland, including GlaxoSmithKline, Sandoz, ICI and Organon. He has specific expertise in design and implementation of business systems, operations management, process improvement and cGMP compliance management. Mr. Wright has extensive experience auditing manufacturing facilities around the world as part of Due Diligence. In addition to directing manufacturing and quality assurance operations for Tribute Pharmaceuticals, Mr. Wright continues to serves as Executive Director, CMC and Audit Group with CanReg Inc. Mr. Wright received his B.Sc. in Chemistry and an M. Sc. in Analytical Chemistry from the University of Strathclyde, Glasgow, U.K. in 1984.

Research Interest

Business Management